MabThera in Rheumatoid Arthritis - Virtual Press Office

Here you can download the EULAR 2007 media materials


Press Release

Latest data show MabThera® provides significant and sustained relief from signs and symptoms of rheumatoid arthritis

Backgrounders

MabThera in rheumatoid arthritis

Roche in rheumatoid arthritis





Key Abstracts

Keystone et al.
Repeated treatment courses of rituximab in rheumatoid arthritis: sustained efficacy in patients with an inadequate response to one or more TNF inhibitors

Emery et al.
Sustained efficacy of repeat treatment courses of rituximab in rheumatoid arthritis patients with an inadequate response to disease-modifying anti-rheumatic drugs

van Vollenhoven et al.
Long-term safety data from extended follow-up and repeat use of rituximab in rheumatoid arthritis

Keystone et al.
Inhibition of radiographic progression with rituximab is not dependent on clinical efficacy: results from a study in rheumatoid arthritis patients with an inadequate response to one or more TNF

B cell events

Video clips and high resolution stills relating to MabThera and rheumatoid arthritis

Image library featuring: diagnosis and symptoms, joint effects, lifestyle, role of B cells and rituximab MOA

• < previous
• next >